CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: Study of ARQ 197 in Hepatocellular Carcinoma (HCC) [Phase 1]
Summary
A Phase 1 trial of ARQ 197 for advanced hepatocellular carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Advanced Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED